{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T06:15:53Z","timestamp":1773296153674,"version":"3.50.1"},"reference-count":43,"publisher":"American Physiological Society","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["American Journal of Physiology-Regulatory, Integrative and Comparative Physiology"],"published-print":{"date-parts":[[2009,9]]},"abstract":"<jats:p> In human medicine, the carbonic anhydrase (CA) inhibitor acetazolamide is used to treat irregular breathing disorders. Previously, we demonstrated in the rabbit that this substance stabilized closed-loop gain properties of the respiratory control system, but concomitantly weakened respiratory muscles. Among others, the highly diffusible CA-inhibitor methazolamide differs from acetazolamide in that it fails to activate Ca<jats:sup>2+<\/jats:sup>-dependent potassium channels in skeletal muscles. Therefore, we aimed to find out, whether or not methazolamide may exert attenuating adverse effects on respiratory muscle performance as acetazolamide. In anesthetized spontaneously breathing rabbits ( n = 7), we measured simultaneously the CO<jats:sub>2<\/jats:sub> responses of tidal phrenic nerve activity, tidal transpulmonary pressure changes, and tidal volume before and after intravenous application of methazolamide at two mean (\u00b1 SE) cumulative doses of 3.5 \u00b1 0.1 and 20.8 \u00b1 0.4 mg\/kg. Similar to acetazolamide, low- and high-dose methazolamide enhanced baseline ventilation by 52 \u00b1 10% and 166 \u00b1 30%, respectively ( P &lt; 0.01) and lowered the base excess in a dose-dependent manner by up to 8.3 \u00b1 0.9 mmol\/l ( P &lt; 0.001). The transmission of a CO<jats:sub>2<\/jats:sub>-induced rise in phrenic nerve activity into volume and\/or pressure and, hence, respiratory work performance was 0.27 \u00b1 0.05 ml\u00b7kg<jats:sup>\u22121<\/jats:sup>\u00b7kPa\u00b7unit<jats:sup>\u22121<\/jats:sup> under control conditions, but remained unchanged upon low- or high-dose methazolamide, at 0.30 \u00b1 0.06 and 0.28 \u00b1 0.07 ml\u00b7kg<jats:sup>\u22121<\/jats:sup>\u00b7kPa\u00b7unit<jats:sup>\u22121<\/jats:sup>, respectively. We conclude that methazolamide does not cause respiratory muscle weakening at elevated levels of ventilatory drive. This substance (so far not used for medication of respiratory diseases) may thus exert stabilizing influences on breathing control without adverse effects on respiratory muscle function. <\/jats:p>","DOI":"10.1152\/ajpregu.00134.2009","type":"journal-article","created":{"date-parts":[[2009,6,24]],"date-time":"2009-06-24T21:59:42Z","timestamp":1245880782000},"page":"R648-R654","source":"Crossref","is-referenced-by-count":7,"title":["Methazolamide does not impair respiratory work performance in anesthetized rabbits"],"prefix":"10.1152","volume":"297","author":[{"given":"Heidrun F.","family":"Kiwull-Sch\u00f6ne","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter J.","family":"Kiwull","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luc J.","family":"Teppema","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"24","reference":[{"key":"R1","doi-asserted-by":"publisher","DOI":"10.1089\/1527029041352108"},{"key":"R2","doi-asserted-by":"publisher","DOI":"10.1580\/1080-6032(2004)015[0032:IOHPVP]2.0.CO;2"},{"key":"R3","doi-asserted-by":"publisher","DOI":"10.1007\/0-387-31311-7_40"},{"key":"R4","doi-asserted-by":"crossref","unstructured":"Bradwell AR, Dykes PW, Coote JH, Forster PJ, Milles JJ, Chesner I, Richardson NV. Effect of acetazolamide on exercise performance and muscle mass at high altitude. Lancet 8488: 1001\u20131005, 1986.","DOI":"10.1016\/S0140-6736(86)91272-9"},{"key":"R5","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-4598(199712)20:12<1541::AID-MUS9>3.0.CO;2-8"},{"key":"R6","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00007.2004"},{"key":"R7","doi-asserted-by":"crossref","unstructured":"Forster P. Methazolamide in acute mountain sickness. Lancet 319: 1254, 1982.","DOI":"10.1016\/S0140-6736(82)92385-6"},{"key":"R8","doi-asserted-by":"publisher","DOI":"10.1042\/CS20050233"},{"key":"R9","doi-asserted-by":"publisher","DOI":"10.1152\/japplphysiol.00746.2001"},{"key":"R10","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.2000.80.2.681"},{"key":"R11","doi-asserted-by":"crossref","unstructured":"H\u00f6hne C, Pickerodt PA, Francis RC, Boemke W, Swenson ER. Pulmonary vasodilatation by acetazolamide during hypoxia is unrelated to carbonic anhydrase inhibition. Am J Physiol Lung Cell Mol Physiol 292: L178\u2013L184, 2007.","DOI":"10.1152\/ajplung.00205.2006"},{"key":"R12","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200507-1035OC"},{"key":"R13","doi-asserted-by":"publisher","DOI":"10.1111\/j.1748-1716.2007.01819.x"},{"key":"R14","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.163.2.9911075"},{"key":"R15","doi-asserted-by":"crossref","unstructured":"Kiwull-Sch\u00f6ne HF, Teppema LJ, Kiwull PJ. Factors of lowered respiratory CO2 sensitivity by acetazolamide in anaesthetized rabbits. CEJ Med 1: 356\u2013369, 2006.","DOI":"10.2478\/s11536-006-0034-7"},{"key":"R16","unstructured":"Kiwull-Sch\u00f6ne H, Teppema L, Wiemann M, Kalhoff H, Kiwull P. Pharmacological impact on loop gain properties to prevent irregular breathing. J Physiol Pharmacol 59: 37\u201345, 2008."},{"key":"R17","doi-asserted-by":"publisher","DOI":"10.1152\/jappl.2000.89.1.200"},{"key":"R18","doi-asserted-by":"publisher","DOI":"10.1152\/japplphysiol.01572.2005"},{"key":"R19","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.155.5.9154862"},{"key":"R20","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.1967.47.4.595"},{"key":"R21","doi-asserted-by":"publisher","DOI":"10.1152\/japplphysiol.00691.2006"},{"key":"R22","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0703825"},{"key":"R23","doi-asserted-by":"publisher","DOI":"10.1152\/jappl.2000.88.2.722"},{"key":"R24","doi-asserted-by":"publisher","DOI":"10.1152\/jappl.1983.55.6.1772"},{"key":"R25","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00161.2006"},{"key":"R26","doi-asserted-by":"crossref","unstructured":"Swenson ER, Hughes JMB. Effects of acute and chronic acetazolamide on resting ventilation and ventilatory responses in man. J Appl Physiol 73: 230\u2013237, 1993.","DOI":"10.1152\/jappl.1993.74.1.230"},{"key":"R27","doi-asserted-by":"publisher","DOI":"10.1016\/0034-5687(91)90104-Q"},{"key":"R28","doi-asserted-by":"publisher","DOI":"10.1016\/0034-5687(78)90018-X"},{"key":"R29","doi-asserted-by":"publisher","DOI":"10.1152\/japplphysiol.01407.2006"},{"key":"R30","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.98.12061242"},{"key":"R31","doi-asserted-by":"publisher","DOI":"10.1177\/000331970105200707"},{"key":"R32","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200608-1199OC"},{"key":"R33","doi-asserted-by":"publisher","DOI":"10.1113\/jphysiol.1995.sp021008"},{"key":"R34","doi-asserted-by":"publisher","DOI":"10.1113\/jphysiol.2006.110528"},{"key":"R35","doi-asserted-by":"publisher","DOI":"10.1113\/jphysiol.2005.104174"},{"key":"R36","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.160.5.9903088"},{"key":"R37","doi-asserted-by":"publisher","DOI":"10.1016\/j.resp.2004.01.001"},{"key":"R38","doi-asserted-by":"publisher","DOI":"10.1096\/fj.03-0722fje"},{"key":"R39","doi-asserted-by":"publisher","DOI":"10.1038\/bjp.2008.42"},{"key":"R40","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2005.10.005"},{"key":"R41","doi-asserted-by":"publisher","DOI":"10.1016\/S0034-5687(98)00010-3"},{"key":"R42","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-7793.2001.0743h.x"},{"key":"R43","unstructured":"Wright AD, Bradwell AR, Fletcher RF. Methazolamide and acetazolamide in acute mountain sickness. Aviat Space Environ Med 54: 619\u2013621, 1983."}],"container-title":["American Journal of Physiology-Regulatory, Integrative and Comparative Physiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.physiology.org\/doi\/pdf\/10.1152\/ajpregu.00134.2009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,8]],"date-time":"2019-09-08T13:12:15Z","timestamp":1567948335000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.physiology.org\/doi\/10.1152\/ajpregu.00134.2009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["10.1152\/ajpregu.00134.2009"],"URL":"https:\/\/doi.org\/10.1152\/ajpregu.00134.2009","relation":{},"ISSN":["0363-6119","1522-1490"],"issn-type":[{"value":"0363-6119","type":"print"},{"value":"1522-1490","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,9]]}}}